These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35266258)

  • 1. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.
    Shah RR; Bhate C; Hernandez A; Ho CH
    Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of severe nivolumab-induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma.
    Mueller KA; Cordisco MR; Scott GA; Plovanich ME
    Pediatr Dermatol; 2023 Jan; 40(1):154-156. PubMed ID: 35882548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
    de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
    Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade.
    Wat M; Mollanazar NK; Ellebrecht CT; Forrestel A; Elenitsas R; Chu EY
    J Cutan Pathol; 2022 Nov; 49(11):978-987. PubMed ID: 36054729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab-induced lichen planus pemphigoides.
    Strickley JD; Vence LM; Burton SK; Callen JP
    Cutis; 2019 Apr; 103(4):224-226. PubMed ID: 31116807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab-induced lichen planus.
    Yilmaz M; Mese SG; Celik U
    J Oncol Pharm Pract; 2020 Apr; 26(3):758-760. PubMed ID: 31382865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine.
    Headd VA; Mathien A; Pei S; Kuraitis D
    Australas J Dermatol; 2024 Jun; 65(4):e97-e99. PubMed ID: 38337182
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus.
    Papara C; Danescu S; Sitaru C; Baican A
    Australas J Dermatol; 2022 May; 63(2):165-171. PubMed ID: 35196400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lichen Planopilaris Pemphigoides: A Novel Bullous Dermatosis Due to Programmed Cell Death Protein-1 Inhibitor Therapy.
    Liu SS; Howard T; Fattah YH; Adams A; Hanly AJ; Karai LJ
    Am J Dermatopathol; 2023 Apr; 45(4):246-249. PubMed ID: 36825932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lichen planus and other lichenoid dermatoses: Kids are not just little people.
    Payette MJ; Weston G; Humphrey S; Yu J; Holland KE
    Clin Dermatol; 2015; 33(6):631-43. PubMed ID: 26686015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichenoid drug eruptions.
    Halevy S; Shai A
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):249-55. PubMed ID: 8335745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text].
    Muntyanu A; Netchiporouk E; Gerstein W; Gniadecki R; Litvinov IV
    J Cutan Med Surg; 2021; 25(1):59-76. PubMed ID: 32746624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions.
    Reschke R; Mockenhaupt M; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2019 Sep; 17(9):942-948. PubMed ID: 31210413
    [No Abstract]   [Full Text] [Related]  

  • 14. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.
    Hübner F; Langan EA; Recke A
    Front Immunol; 2019; 10():1389. PubMed ID: 31312198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simvastatin-induced lichen planus pemphigoides].
    Stoebner PE; Michot C; Ligeron C; Durand L; Meynadier J; Meunier L
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):187-90. PubMed ID: 12671581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
    Sato Y; Fujimura T; Mizuashi M; Aiba S
    J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
    [No Abstract]   [Full Text] [Related]  

  • 17. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
    Matsumoto Y; Kadono T; Matsuoka M; Kawakami T; Furuya N; Doi M; Hoshikawa M; Soma Y
    J Dermatol; 2018 Feb; 45(2):e33-e34. PubMed ID: 28984022
    [No Abstract]   [Full Text] [Related]  

  • 18. Lichen planus pemphigoides induced by anti-PD-1 antibody: A case only involved in oral mucosa with excellent topical treatment efficiency.
    Wang S; Sun J; Deng S; Wu L; Li W; Ye T; Wu F; Wu Y; Zhou H
    J Cutan Pathol; 2024 Feb; 51(2):114-118. PubMed ID: 37846754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-related lichen planus of the lip in a patient with head and neck cancer.
    Economopoulou P; Nicolatou-Galitis O; Kotsantis I; Psyrri A
    Oral Oncol; 2020 May; 104():104623. PubMed ID: 32144002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen Planus Pemphigoides Associated With PD-1 and PD-L1 Inhibitors: A Case Series and Review of the Literature.
    Boyle MM; Ashi S; Puiu T; Reimer D; Sokumbi O; Soltani K; Onajin O
    Am J Dermatopathol; 2022 May; 44(5):360-367. PubMed ID: 35120032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.